These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 17684738)

  • 1. Digoxin and mortality in atrial fibrillation: a prospective cohort study.
    Hallberg P; Lindbäck J; Lindahl B; Stenestrand U; Melhus H;
    Eur J Clin Pharmacol; 2007 Oct; 63(10):959-71. PubMed ID: 17684738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Digoxin on Mortality in Patients With Atrial Fibrillation Stratified by Heart Failure: Findings From Gulf Survey of Atrial Fibrillation Events in the Middle East.
    Al-Zakwani I; Panduranga P; Zubaid M; Sulaiman K; Rashed WA; Alsheikh-Ali AA; AlMahmeed W; Shehab A; Al Qudaimi A; Asaad N; Amin H
    J Cardiovasc Pharmacol Ther; 2016 May; 21(3):273-9. PubMed ID: 26341119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: a prospective cohort study from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).
    Stenestrand U; Lindbäck J; Wallentin L;
    Circulation; 2005 Nov; 112(21):3225-31. PubMed ID: 16301355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure.
    Shah M; Avgil Tsadok M; Jackevicius CA; Essebag V; Behlouli H; Pilote L
    Am J Cardiol; 2014 Aug; 114(3):401-6. PubMed ID: 24950677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
    Washam JB; Stevens SR; Lokhnygina Y; Halperin JL; Breithardt G; Singer DE; Mahaffey KW; Hankey GJ; Berkowitz SD; Nessel CC; Fox KA; Califf RM; Piccini JP; Patel MR;
    Lancet; 2015 Jun; 385(9985):2363-70. PubMed ID: 25749644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should digoxin be proscribed in elderly subjects in sinus rhythm free from heart failure? A population-based study.
    Casiglia E; Tikhonoff V; Pizziol A; Onesto C; Ginocchio G; Mazza A; Pessina AC
    Jpn Heart J; 1998 Sep; 39(5):639-51. PubMed ID: 9925995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased mortality among patients taking digoxin--analysis from the AFFIRM study.
    Whitbeck MG; Charnigo RJ; Khairy P; Ziada K; Bailey AL; Zegarra MM; Shah J; Morales G; Macaulay T; Sorrell VL; Campbell CL; Gurley J; Anaya P; Nasr H; Bai R; Di Biase L; Booth DC; Jondeau G; Natale A; Roy D; Smyth S; Moliterno DJ; Elayi CS
    Eur Heart J; 2013 May; 34(20):1481-8. PubMed ID: 23186806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digoxin in atrial fibrillation: report from the Stockholm Cohort study of Atrial Fibrillation (SCAF).
    Friberg L; Hammar N; Rosenqvist M
    Heart; 2010 Feb; 96(4):275-80. PubMed ID: 19710030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digoxin-associated mortality: a systematic review and meta-analysis of the literature.
    Vamos M; Erath JW; Hohnloser SH
    Eur Heart J; 2015 Jul; 36(28):1831-8. PubMed ID: 25939649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
    O'Meara E; Khairy P; Blanchet MC; de Denus S; Pedersen OD; Levesque S; Talajic M; Ducharme A; White M; Racine N; Rouleau JL; Tardif JC; Roy D;
    Circ Heart Fail; 2012 Sep; 5(5):586-93. PubMed ID: 22798522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does digoxin increase the risk of ischemic stroke and mortality in atrial fibrillation? A nationwide population-based cohort study.
    Chao TF; Liu CJ; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Chiang CE; Chen SA
    Can J Cardiol; 2014 Oct; 30(10):1190-5. PubMed ID: 25262860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial.
    Gheorghiade M; Fonarow GC; van Veldhuisen DJ; Cleland JG; Butler J; Epstein AE; Patel K; Aban IB; Aronow WS; Anker SD; Ahmed A
    Eur Heart J; 2013 May; 34(20):1489-97. PubMed ID: 23592708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation.
    Pastori D; Farcomeni A; Bucci T; Cangemi R; Ciacci P; Vicario T; Violi F; Pignatelli P
    Int J Cardiol; 2015 Feb; 180():1-5. PubMed ID: 25460369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digoxin Is Associated With Increased All-cause Mortality in Patients With Atrial Fibrillation Regardless of Concomitant Heart Failure: A Meta-analysis.
    Wang ZQ; Zhang R; Chen MT; Wang QS; Zhang Y; Huang XH; Wang J; Yan JH; Li YG
    J Cardiovasc Pharmacol; 2015 Sep; 66(3):270-5. PubMed ID: 26348825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.
    Freeman JV; Reynolds K; Fang M; Udaltsova N; Steimle A; Pomernacki NK; Borowsky LH; Harrison TN; Singer DE; Go AS
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):49-58. PubMed ID: 25414270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Curtis AB; Gersh BJ; Corley SD; DiMarco JP; Domanski MJ; Geller N; Greene HL; Kellen JC; Mickel M; Nelson JD; Rosenberg Y; Schron E; Shemanski L; Waldo AL; Wyse DG;
    Am Heart J; 2005 Apr; 149(4):645-9. PubMed ID: 15990747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial.
    Am Heart J; 2002 Oct; 144(4):597-607. PubMed ID: 12360154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure.
    Frasure-Smith N; Lespérance F; Habra M; Talajic M; Khairy P; Dorian P; Roy D;
    Circulation; 2009 Jul; 120(2):134-40, 3p following 140. PubMed ID: 19564557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment Failure With Rhythm and Rate Control Strategies in Patients With Atrial Fibrillation and Congestive Heart Failure: An AF-CHF Substudy.
    Dyrda K; Roy D; Leduc H; Talajic M; Stevenson LW; Guerra PG; Andrade J; Dubuc M; Macle L; Thibault B; Rivard L; Khairy P
    J Cardiovasc Electrophysiol; 2015 Dec; 26(12):1327-32. PubMed ID: 26332293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality in heart failure with atrial fibrillation: Role of digoxin and diuretics.
    Gonzalez-Loyola F; Abellana R; Verdú-Rotellar JM; Bustamante Rangel A; Clua-Espuny JL; Muñoz MA
    Eur J Clin Invest; 2018 Nov; 48(11):e13014. PubMed ID: 30091171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.